ENDRA Life Sciences Inc. Warrants (NDRAW) Key Ratios
$0.02
As on 12-May-2022 16:00EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | 8.03 | -10.76 | 42.22 | -12.22 | -244.97 |
| Net Profit | 11.39 | -25.95 | -41.60 | -8.29 | -212.55 |
| EPS | 11.39 | -25.95 | -41.60 | 16.52 | 12.48 |
| Book Value | -- | -- | 50.42 | -17.41 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-21 | Dec-20 |
| EBIT-Margin
| -- | -80,099.39 | -- | -- | -- |
| Net Margin
| 5,244.34 | 5,244.34 | -1,099,562.34 | -- | 5,244.34 |
| Return on equity
| -213.81 | -211.37 | -107.46 | -126.46 | -196.57 |
| Return on Capital
| -201.52 | -195.26 | -- | -117.53 | -180.05 |
| Return on Assets
| -166.78 | -161.94 | -74.73 | -106.59 | -150.31 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.06 | 0.10 |
The underlying data is unavailable.